Valuation: Innovotech Inc.

Market Cap 3.54M 2.49M 2.21M 2.07M 1.88M 240M 3.57M 24.86M 9.65M 123M 9.35M 9.15M 394M P/E 2024
36x
P/E 2025 143x
Enterprise Value 2.08M 1.46M 1.3M 1.22M 1.1M 141M 2.1M 14.61M 5.67M 72.05M 5.49M 5.38M 231M EV / Sales 2024
3.75x
EV / Sales 2025 2.72x
Free-Float
58.13%
Yield 2024 *
-
Yield 2025 -
1 week-7.14%
Current month-7.14%
1 month-13.33%
3 months-23.53%
6 months-62.86%
Current year-75.47%
1 week 0.06
Extreme 0.065
0.07
1 month 0.06
Extreme 0.065
0.08
Current year 0.06
Extreme 0.065
0.28
1 year 0.06
Extreme 0.065
0.29
3 years 0.02
Extreme 0.02
0.34
5 years 0.02
Extreme 0.02
0.34
10 years 0.02
Extreme 0.015
0.34
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2023-12-11
Chief Executive Officer - 2014-08-26
Director TitleAgeSince
Chairman - 2014-01-19
Director/Board Member 63 2018-08-12
Director/Board Member - 2019-07-18
Date Insider Type Main position Quantity % Market Cap. Importance
9/24/26 Buy

Director

900 0.0017%
9/1/26 Buy

Director

50,000 0.0918%
8/24/26 Buy

Director

90,000 0.1653%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-7.14%-69.05%-35.00% 2.48M
+4.16%+3.42%+49.37%+94.17% 74.31B
+2.76%-1.16%+23.05%+83.03% 56.95B
+0.24%-1.37%+4.08%+37.22% 48.3B
-3.76%-0.93%+327.90%+691.25% 44.51B
-2.30%-4.06%+25.82%+31.42% 43.8B
+0.31%-1.15%+5.50%+112.56% 41.12B
-0.11%+2.30%+9.19%+58.68% 31.07B
+4.51%+8.43%+37.27%+34.97% 28.97B
-1.96%-3.38%-9.25%-12.85% 24.53B
Average +0.39%-0.90%+40.39%+109.55% 39.36B
Weighted average by Cap. +0.77%-0.50%+56.58%+134.21%

Financials

2024 2025
Net sales 2.19M 1.54M 1.37M 1.28M 1.16M 149M 2.21M 15.42M 5.99M 76.03M 5.8M 5.67M 244M 4.53M 3.19M 2.83M 2.65M 2.41M 308M 4.57M 31.86M 12.37M 157M 11.98M 11.73M 504M
Net income 225K 158K 140K 131K 119K 15.24M 227K 1.58M 613K 7.79M 594K 581K 25M 94.38K 66.38K 58.99K 55.16K 50.06K 6.4M 95.17K 663K 257K 3.27M 249K 244K 10.5M
Net Debt -725K -510K -453K -424K -385K -49.2M -731K -5.1M -1.98M -25.13M -1.92M -1.88M -80.7M -1.46M -1.03M -912K -853K -774K -98.97M -1.47M -10.25M -3.98M -50.56M -3.86M -3.77M -162M
Projected Income Statement - Annual - Innovotech Inc.
Logo Innovotech Inc.
Innovotech Inc. is a diversified Canadian technology company with business operations in a portfolio of specialized laboratory services, biotechnology businesses, and proprietary intellectual property. Innovotech Labs Corporation, a wholly owned subsidiary, is a contract research organization that owns and provides proprietary devices for antimicrobial testing in multiple applications and commercializes antimicrobial silver solutions. Its operating company, Keystone Labs Inc. is a lab serving the Canadian pharmaceutical industry and industrial markets. The Company has offerings in antimicrobial contract services and is the vendor for several global medical device companies. It owns a 60% interest in Noulife Sciences Inc., a company that owns intellectual property for linked antioxidant molecules commonly used in skin care and in the treatment of certain medical conditions. It also manufactures and sells several types of laboratory consumables. It manages several subsidiary companies.
Employees
16
Date Price Change Volume
26-10-05 $0.0650 0.00% 124,948